Wanigatunge, C., 2017. Update on newer antidiabetic drugs in clinical practice. Journal of the Postgraduate Institute of Medicine, 4(2), pp.E57 1–10. DOI: http://doi.org/10.4038/jpgim.8171

Wanigatunge C. Update on newer antidiabetic drugs in clinical practice. Journal of the Postgraduate Institute of Medicine. 2017;4(2):E57 1–10. DOI: http://doi.org/10.4038/jpgim.8171

Wanigatunge, C. (2017). Update on newer antidiabetic drugs in clinical practice. Journal of the Postgraduate Institute of Medicine, 4(2), E57 1–10. DOI: http://doi.org/10.4038/jpgim.8171

1. Wanigatunge C. Update on newer antidiabetic drugs in clinical practice. Journal of the Postgraduate Institute of Medicine. 2017;4(2):E57 1-10. DOI: http://doi.org/10.4038/jpgim.8171

Wanigatunge C, ‘Update on Newer Antidiabetic Drugs in Clinical Practice’ (2017) 4 Journal of the Postgraduate Institute of Medicine E57 1 DOI: http://doi.org/10.4038/jpgim.8171

Wanigatunge, Chandanie. 2017. “Update on Newer Antidiabetic Drugs in Clinical Practice”. Journal of the Postgraduate Institute of Medicine 4 (2): E57 1–10. DOI: http://doi.org/10.4038/jpgim.8171

Wanigatunge, Chandanie. “Update on Newer Antidiabetic Drugs in Clinical Practice”. Journal of the Postgraduate Institute of Medicine 4, no. 2 (2017): E57 1–10. DOI: http://doi.org/10.4038/jpgim.8171

Wanigatunge, C. “Update on newer antidiabetic drugs in clinical practice”. Journal of the Postgraduate Institute of Medicine, vol. 4, no. 2, 2017, pp. E57 1–10. DOI: http://doi.org/10.4038/jpgim.8171